TUSTIN, Calif., Nov. 1, 2024 /PRNewswire/ — Pangea Laboratory has partnered with Unilabs, a leading European provider of clinical laboratory testing and diagnostic imaging services, to introduce the Bladder CARE™ test in Switzerland . As part of this agreement, the Bladder CARE™ test will be covered by insurance companies, improving access for patients. This strategic collaboration aims to streamline cancer diagnostics in Switzerland, with plans for a wider rollout of Bladder CARE™ across Europe. This partnership highlights Pangea Laboratory’s commitment to making innovative diagnostic solutions widely accessible around the world.
Awarded Breakthrough Device designation by the FDA, the Bladder CARE™ test analyzes DNA methylation biomarkers to detect bladder cancer and upper tract urothelial carcinoma (UTUC) from urine samples, which can be conveniently collected at home. With sensitivity, specificity and NPV greater than 93% for both pathologies, as well as quantitative results, the Bladder CARE™ test stands out from other commercially available tests.
“Through this strategic partnership with Pangea Laboratory, Unilabs strengthens its commitment to driving innovation in diagnostics, bringing Bladder CARE™ to Switzerland as a next-generation solution that strengthens early detection and advances patient care. patients,” said Patrick Bornand, head of pathology, genetics and oncology at Unilabs Switzerland.
“Pangea Laboratory is committed to providing non-invasive healthcare solutions that reduce patient burden while providing highly accurate results. We are pleased that the Unilabs team shares our vision and the belief that Bladder CARE™ establishes a new standard in the diagnosis of bladder cancer and UTUC,” said Dr. Yap Ching Chew, Chief Operating Officer of Pangea Laboratory.
About the Pangea laboratory
Founded in 2014, Pangea Laboratory is a Clinical Laboratory Improvement Amendments (CLIA) certified and College of American Pathologists (CAP) accredited diagnostic company dedicated to simplifying the diagnosis of critical health conditions. For more information, visit the website https://pangealab.com/bladdercare/.
About Unilabs
Unilabs is a leading European provider of clinical laboratory testing and medical diagnostic imaging services, with more than 109 laboratories and 44 imaging units across 12 countries. Headquartered in Geneva, Unilabs performs more than 106 million diagnostic tests and 1 million radiological examinations each year, serving healthcare providers, governments, pharmaceutical companies and the public. Unilabs focuses on rapid and accurate diagnosis and aims to move from treatment to prediction and prevention, thanks to advances in molecular and genetic testing. For more information, visit the website www.unilabs.com.
Contacts :
Pangea Laboratory
Abigail Kang, Marketing Manager
[email protected]
Unilabs Switzerland
Inês Camilo, Marketing Specialist
[email protected]
WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
